
A 5-day course of azithromycin is associated with an increased risk of cardiovascular death, according to a recently published retrospective cohort study. Key Point: Azithromycin appears to have an adverse cardiac effect, possibly as a result of being proarrhythmic. The risk:benefit profile should be carefully considered before prescribing this agent,…
Read more »
Azithromycin found to increase risk of cardiovascular death
A 5-day course of azithromycin is associated with an increased risk of cardiovascular death, according to a recently published retrospective cohort study. Key Point: Azithromycin appears to have an adverse cardiac effect, possibly as a result of being proarrhythmic. The risk:benefit profile should be carefully considered before prescribing this agent,…
Read more »